Mark Elliott Boulding
Exec. VP and CLO at PTC Therapeutics · 95 reported transactions in 1 company · latest trade Oct 9, 2026
Their trades
Sold | Oct 9, 2026 | Oct 9, 2026 close $64.70 → Oct 29, 2026 close $64.46. S&P 500 −1.2% over the same days. | ||
Sold | Oct 6, 2026 | Oct 6, 2026 close $63.70 → Oct 29, 2026 close $64.46. S&P 500 −1.3% over the same days. | ||
Sold | Oct 5, 2026 | Oct 5, 2026 close $63.65 → Oct 29, 2026 close $64.46. S&P 500 −0.7% over the same days. | ||
Sold | Aug 17, 2026 | Aug 17, 2026 close $72.88 → Oct 29, 2026 close $64.46. S&P 500 −0.4% over the same days. | ||
Sold | Aug 17, 2026 | Aug 17, 2026 close $72.88 → Oct 29, 2026 close $64.46. S&P 500 −0.4% over the same days. | ||
Sold | Jul 6, 2026 | Jul 6, 2026 close $85.44 → Oct 29, 2026 close $64.46. S&P 500 +2.4% over the same days. |
SoldPTC Therapeutics
$12.3K
Oct 9, 2026 close $64.70 → Oct 29, 2026 close $64.46. S&P 500 −1.2% over the same days.
SoldPTC Therapeutics
$27.9K
Oct 6, 2026 close $63.70 → Oct 29, 2026 close $64.46. S&P 500 −1.3% over the same days.
SoldPTC Therapeutics
$104.9K
Oct 5, 2026 close $63.65 → Oct 29, 2026 close $64.46. S&P 500 −0.7% over the same days.
SoldPTC Therapeutics
$70.6K
Aug 17, 2026 close $72.88 → Oct 29, 2026 close $64.46. S&P 500 −0.4% over the same days.
SoldPTC Therapeutics
$133.5K
Aug 17, 2026 close $72.88 → Oct 29, 2026 close $64.46. S&P 500 −0.4% over the same days.
SoldPTC Therapeutics
$64.4K
Jul 6, 2026 close $85.44 → Oct 29, 2026 close $64.46. S&P 500 +2.4% over the same days.